<DOC>
	<DOCNO>NCT02105493</DOCNO>
	<brief_summary>Trans-radial approach ( TRA ) become popular widely adopt last decade . However , radial artery occlusion ( RAO ) continue one limitation trans-radial access potentially limit radial artery access site future . Several strategy use decrease incidence RAO include use anticoagulation , maintenance patency hemostasis , shorten duration compression . Currently , data whether vasoactive pharmacological therapy nitroglycerin administer intra-arterially end procedure may reduce incidence RAO . It hypothesize addition nitroglycerin ( nitric oxide donor ) end TRA procedure may reduce incidence RAO .</brief_summary>
	<brief_title>Nitroglycerin Prevents Radial Artery Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Sequential patient undergo transradial catheterization institution consent randomized receive either 500 microgram nitroglycerin ( Group A ) placebo ( Group B ) administer intraarterially sheath end procedure . Patients cardiogenic shock hemodynamically unstable Unable tolerate nitrate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Nitroglycerin</keyword>
	<keyword>Radial Artery Occlusion</keyword>
	<keyword>Transradial Catheterization</keyword>
</DOC>